X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18) 18
humans (17) 17
female (14) 14
children (13) 13
hiv (13) 13
child, preschool (11) 11
hiv infections - drug therapy (11) 11
immunology (11) 11
infectious diseases (11) 11
male (11) 11
child (9) 9
antiretroviral drugs (8) 8
drug therapy (8) 8
human immunodeficiency virus--hiv (8) 8
infant (8) 8
nevirapine - therapeutic use (8) 8
anti-hiv agents - therapeutic use (7) 7
antiretroviral therapy (7) 7
hiv infection (7) 7
acquired immune deficiency syndrome--aids (6) 6
health aspects (6) 6
nevirapine (6) 6
pediatrics (6) 6
antiviral agents (5) 5
article (5) 5
cd4 lymphocyte count (5) 5
cohort studies (5) 5
hiv infections - virology (5) 5
lopinavir - therapeutic use (5) 5
prevention (5) 5
ritonavir - therapeutic use (5) 5
treatment outcome (5) 5
uganda (5) 5
usage (5) 5
adolescent (4) 4
africa (4) 4
aids/hiv (4) 4
dosage and administration (4) 4
highly active antiretroviral therapy (4) 4
hiv infection in children (4) 4
hiv infections - prevention & control (4) 4
lamivudine - therapeutic use (4) 4
lopinavir (4) 4
microbiology (4) 4
research article (4) 4
risk assessment (4) 4
risk factors (4) 4
transmission (4) 4
viral load (4) 4
women (4) 4
aids (3) 3
antiretroviral therapy, highly active (3) 3
care and treatment (3) 3
children & youth (3) 3
comparative analysis (3) 3
complications and side effects (3) 3
drug-resistance (3) 3
drugs (3) 3
exposure (3) 3
growth (3) 3
hiv infections - epidemiology (3) 3
hiv infections - immunology (3) 3
hiv patients (3) 3
hiv-1 (3) 3
hiv-1-infected children (3) 3
infants (3) 3
mortality (3) 3
pregnancy (3) 3
randomized controlled-trial (3) 3
research (3) 3
therapy (3) 3
uganda - epidemiology (3) 3
zidovudine (3) 3
zidovudine - therapeutic use (3) 3
abridged index medicus (2) 2
acquired immune deficiency syndrome (2) 2
adolescents (2) 2
adult (2) 2
ambulatory care facilities (2) 2
analysis (2) 2
anti-hiv agents - adverse effects (2) 2
anti-retroviral agents - therapeutic use (2) 2
antimalarials (2) 2
antiretroviral agents (2) 2
antiviral therapy (2) 2
attention (2) 2
biology and life sciences (2) 2
breast feeding (2) 2
cd4 cell response (2) 2
child development (2) 2
clinical trials (2) 2
development and progression (2) 2
disease transmission (2) 2
drug dosages (2) 2
drug therapy, combination (2) 2
executive function (2) 2
failure (2) 2
follow-up studies (2) 2
forecasts and trends (2) 2
health care sciences & services (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 25, pp. 2380 - 2389
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 06/2015, Volume 60, p. S177
  This systematic review aimed to assess the safety and efficacy of antiretroviral options for postexposure prophylaxis (PEP). Recognizing the limited data on... 
Antiretroviral drugs | Pediatrics | Human immunodeficiency virus--HIV | Risk assessment | Meta-analysis | Children & youth
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, p. e0186589
Journal Article
BMC PREGNANCY AND CHILDBIRTH, ISSN 1471-2393, 10/2019, Volume 19, Issue 1, pp. 1 - 9
Background In 2010, the World Health Assembly passed a resolution calling upon countries to prevent birth defects where possible. Though birth defects... 
MIDDLE-INCOME COUNTRIES | Hospital-based surveillance | Congenital anomalies | Uganda | Birth defects | PREVALENCE | Birth prevalence | CONGENITAL-ANOMALIES | OBSTETRICS & GYNECOLOGY
Journal Article
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ISSN 1058-4838, 12/2019
Children living with human immunodeficiency virus (HIV) are at neuropsychological risk for cognitive and motor dysfunction. However, few prospective,... 
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, p. e0165140
Background HIV and malaria geographically overlap. HIV protease inhibitors kill malaria parasites in vitro and in vivo, but further evaluation in clinical... 
PLASMODIUM-FALCIPARUM | MULTIDISCIPLINARY SCIENCES | PREVENTION | NEVIRAPINE | EXPOSURE | PCR | BLOOD | Coinfection | Humans | Child, Preschool | Infant | Male | Nevirapine - therapeutic use | Plasmodium falciparum - drug effects | HIV Infections - immunology | HIV-1 - growth & development | Malawi | Lamivudine - therapeutic use | Ritonavir - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Child | Malaria, Falciparum - drug therapy | HIV-1 - drug effects | HIV Infections - virology | Antimalarials - therapeutic use | CD4 Lymphocyte Count | HIV Protease Inhibitors - therapeutic use | Malaria, Falciparum - parasitology | Malaria, Falciparum - immunology | HIV Infections - drug therapy | HIV-1 - enzymology | Lopinavir - therapeutic use | Zidovudine - therapeutic use | Plasmodium falciparum - growth & development | Viral Load - drug effects | Highly active antiretroviral therapy | Complications and side effects | Usage | Malaria | Demographic aspects | Physiological aspects | Genetic aspects | Research | HIV infection | Risk factors | Therapy | RNA-directed DNA polymerase | Nevirapine | Ritonavir | Parasites | Medical diagnosis | Optimization | Acquired immune deficiency syndrome--AIDS | Protease | Antiretroviral agents | Human immunodeficiency virus--HIV | Smear | Children | Vector-borne diseases | Antiretroviral drugs | Lopinavir | Health risks | Lamivudine | Proteinase inhibitors | Antiretroviral therapy | Protease inhibitors | Microscopy | Nucleosides | In vivo methods and tests | Zidovudine | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article